CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape Journal Article


Authors: Hamieh, M.; Dobrin, A.; Cabriolu, A.; van der Stegen, S. J. C.; Giavridis, T.; Mansilla-Soto, J.; Eyquem, J.; Zhao, Z.; Whitlock, B. M.; Miele, M. M.; Li, Z.; Cunanan, K. M.; Huse, M.; Hendrickson, R. C.; Wang, X.; Rivière, I.; Sadelain, M.
Article Title: CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
Abstract: Chimeric antigen receptors (CARs) are synthetic antigen receptors that reprogram T cell specificity, function and persistence 1 . Patient-derived CAR T cells have demonstrated remarkable efficacy against a range of B-cell malignancies 1–3 , and the results of early clinical trials suggest activity in multiple myeloma 4 . Despite high complete response rates, relapses occur in a large fraction of patients; some of these are antigen-negative and others are antigen-low 1,2,4–9 . Unlike the mechanisms that result in complete and permanent antigen loss 6,8,9 , those that lead to escape of antigen-low tumours remain unclear. Here, using mouse models of leukaemia, we show that CARs provoke reversible antigen loss through trogocytosis, an active process in which the target antigen is transferred to T cells, thereby decreasing target density on tumour cells and abating T cell activity by promoting fratricide T cell killing and T cell exhaustion. These mechanisms affect both CD28- and 4-1BB-based CARs, albeit differentially, depending on antigen density. These dynamic features can be offset by cooperative killing and combinatorial targeting to augment tumour responses to immunotherapy. © 2019, The Author(s), under exclusive licence to Springer Nature Limited.
Keywords: controlled study; protein expression; unclassified drug; nonhuman; letter; protein localization; animal cell; mouse; cell death; cell survival; cell protein; animal experiment; animal model; tumor antigen; granzyme b; regulatory mechanism; gamma interferon; cell damage; tumor cell; chimeric antigen receptor; cytokine production; density; leukemia relapse; cell activity; cell expansion; cd19 antigen; cd28 antigen; cell killing; mesothelin; cd22 antigen; programmed death 1 receptor; tumor escape; antigen density; male; female; priority journal; b cell maturation antigen; lag 3 protein; trogocytosis; cell exhaustion; hepatitis a virus cellular receptor 2; tumor necrosis factor receptor superfamily member 9; cd19 gene; phenomena and functions of biological membrane
Journal Title: Nature
Volume: 568
Issue: 7750
ISSN: 0028-0836
Publisher: Nature Publishing Group  
Date Published: 2019-04-04
Start Page: 112
End Page: 116
Language: English
DOI: 10.1038/s41586-019-1054-1
PUBMED: 30918399
PROVIDER: scopus
PMCID: PMC6707377
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Morgan Huse
    68 Huse
  2. Michel W J Sadelain
    583 Sadelain
  3. Isabelle C Riviere
    240 Riviere
  4. Zeguo Zhao
    26 Zhao
  5. Xiuyan Wang
    118 Wang
  6. Mohamad   Hamieh
    27 Hamieh
  7. Justin Gabriel Andre Francois Eyquem
    25 Eyquem
  8. Matthew M Miele
    18 Miele
  9. Anton Dobrin
    20 Dobrin
  10. Zhuoning Li
    17 Li